Eagle Asset Management Inc. Cuts Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Eagle Asset Management Inc. decreased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 19.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 362,650 shares of the biotechnology company’s stock after selling 90,323 shares during the quarter. Axon Enterprise accounts for 0.8% of Eagle Asset Management Inc.’s portfolio, making the stock its 27th largest position. Eagle Asset Management Inc. owned about 0.48% of Axon Enterprise worth $144,915,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of AXON. CIBC Asset Management Inc boosted its stake in shares of Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares in the last quarter. Foundations Investment Advisors LLC purchased a new position in shares of Axon Enterprise during the third quarter valued at approximately $221,000. Sequoia Financial Advisors LLC increased its holdings in shares of Axon Enterprise by 4.9% during the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after acquiring an additional 81 shares in the last quarter. Axxcess Wealth Management LLC purchased a new stake in Axon Enterprise during the 3rd quarter valued at $814,000. Finally, Jag Capital Management LLC lifted its stake in Axon Enterprise by 9.7% during the 3rd quarter. Jag Capital Management LLC now owns 56,086 shares of the biotechnology company’s stock valued at $22,412,000 after acquiring an additional 4,954 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $632.04 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $224.28 and a twelve month high of $640.51. The business has a 50-day moving average price of $458.43 and a 200-day moving average price of $365.54. The firm has a market cap of $48.19 billion, a price-to-earnings ratio of 163.32, a price-to-earnings-growth ratio of 18.26 and a beta of 0.94.

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the business’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the sale, the president now owns 208,166 shares in the company, valued at $126,179,820.90. The trade was a 8.77 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 330,256 shares of company stock valued at $131,338,820. Corporate insiders own 6.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on AXON shares. Northland Securities increased their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. JMP Securities increased their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Barclays boosted their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Craig Hallum increased their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Finally, The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $427.83.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.